This isn’t FISHER WALLACE LABORATORIES’s most recent raise. Reg CF · Common Stock · Oct 2026 (Open) is more current.View latest round
via DealMaker · last checked Sep 23, 2026
Raised
$195.5K / $2.6M max
8% of ceiling
Investors
158
$1.2K avg
Post-money valuation
$120.2M
pre-money + amount raised
Financials disclosed in this offering
FY2023–FY2024 · hover for source$4.7M
−$7.1M
FY2023
$47K
−$1.6M
FY2024
RevenueNet income
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$4,739,387
$47,412
Cost of goods sold
$1,096,113
$3,012
Gross margin
77%
94%
Net income
-$7,073,744
-$1,579,900
Taxes paid
$0
$0
Balance sheet
Cash
$128,229
$41,626
Accounts receivable
$0
$0
Total assets
$439,495
$154,382
Short-term debt
$427,470
$596,721
Long-term debt
$1,083,664
$925,582
Total liabilities
$4,089,159
$1,522,303
Other
Headcount
3
2
The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Deal terms
Pre-money$120M
Post-money$120.2M
Price / share$11.19
Shares offered8,937
Offering details
Target$103,505
Max$2,587,503
Min investment—
OpenedNov 24, 2025
DeadlineDec 15, 2025
ClosedDec 15, 2025
Days active21
Links & provenance
Source: SEC EDGAR
0001787792-25-000010
Last synced Sep 23, 2026
0001787792-25-000010
Last synced Sep 23, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.